Literature DB >> 27986445

NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis.

Andrey Lozhkin1, Aleksandr E Vendrov1, Hua Pan2, Samuel A Wickline2, Nageswara R Madamanchi1, Marschall S Runge3.   

Abstract

We recently reported that increased NADPH oxidase 4 (NOX4) expression and activity during aging results in enhanced cellular and mitochondrial oxidative stress, vascular inflammation, dysfunction, and atherosclerosis. The goal of the present study was to elucidate the molecular mechanism(s) for these effects and determine the importance of NOX4 modulation of proinflammatory gene expression in mouse vascular smooth muscle cells (VSMCs). A novel peptide-mediated siRNA transfection approach was used to inhibit Nox4 expression with minimal cellular toxicity. Using melittin-derived peptide p5RHH, we achieved significantly higher transfection efficiency (92% vs. 85% with Lipofectamine) and decreased toxicity (p<0.001 vs. Lipofectamine in MTT and p<0.0001 vs. Lipofectamine in LDH assays) in VSMCs. TGFβ1 significantly upregulates Nox4 mRNA (p<0.01) and protein (p<0.01) expression in VSMCs. p5RHH-mediated Nox4 siRNA transfection greatly attenuated TGFβ1-induced upregulation of Nox4 mRNA (p<0.01) and protein (p<0.0001) levels and decreased hydrogen peroxide production (p<0.0001). Expression of pro-inflammatory genes Ccl2, Ccl5, Il6, and Vcam1 was significantly upregulated in VSMCs in several settings cells isolated from aged vs. young wild-type mice, in atherosclerotic arteries of Apoe-/- mice, and atherosclerotic human carotid arteries and correlated with NOX4 expression. p5RHH-mediated Nox4 siRNA transfection significantly attenuated the expression of these pro-inflammatory genes in TGFβ1-treated mouse VSMCs, with the highest degree of inhibition in the expression of Il6. p5RHH peptide-mediated knockdown of TGFβ-activated kinase 1 (TAK1, also known as Map3k7), Jun, and Rela, but not Nfkb2, downregulated TGFβ1-induced Nox4 expression in VSMCs. Together, these data demonstrate that increased expression and activation of NOX4, which might result from increased TGFβ1 levels seen during aging, induces a proinflammatory phenotype in VSMCs, enhancing atherosclerosis. Copyright Â
© 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Atherosclerosis; Cytokines; Inflammation; Nanoparticles; Reactive oxygen species

Mesh:

Substances:

Year:  2016        PMID: 27986445      PMCID: PMC5625334          DOI: 10.1016/j.yjmcc.2016.12.004

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  73 in total

Review 1.  Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.

Authors:  Ian Toma; Timothy A McCaffrey
Journal:  Cell Tissue Res       Date:  2011-05-31       Impact factor: 5.249

2.  Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.

Authors:  Kirk K Hou; Hua Pan; Lee Ratner; Paul H Schlesinger; Samuel A Wickline
Journal:  ACS Nano       Date:  2013-09-26       Impact factor: 15.881

3.  Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.

Authors:  James A de Lemos; David A Morrow; Michael A Blazing; Petr Jarolim; Stephen D Wiviott; Marc S Sabatine; Robert M Califf; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2007-11-13       Impact factor: 24.094

Review 4.  NADPH oxidases: functions and pathologies in the vasculature.

Authors:  Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

5.  Rosiglitazone attenuates NF-κB-mediated Nox4 upregulation in hyperglycemia-activated endothelial cells.

Authors:  Clintoria R Williams; Xianghuai Lu; Roy L Sutliff; C Michael Hart
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-09       Impact factor: 4.249

6.  Nox4: a hydrogen peroxide-generating oxygen sensor.

Authors:  Yukio Nisimoto; Becky A Diebold; Daniela Cosentino-Gomes; Daniela Constentino-Gomes; J David Lambeth
Journal:  Biochemistry       Date:  2014-08-01       Impact factor: 3.162

7.  The NADPH oxidase Nox4 has anti-atherosclerotic functions.

Authors:  Christoph Schürmann; Flavia Rezende; Christoph Kruse; Yakub Yasar; Oliver Löwe; Christian Fork; Bart van de Sluis; Rolf Bremer; Norbert Weissmann; Ajay M Shah; Hanjoong Jo; Ralf P Brandes; Katrin Schröder
Journal:  Eur Heart J       Date:  2015-09-17       Impact factor: 29.983

8.  NADPH oxidase 4 regulates cardiomyocyte differentiation via redox activation of c-Jun protein and the cis-regulation of GATA-4 gene transcription.

Authors:  Thomas V A Murray; Ioannis Smyrnias; Ajay M Shah; Alison C Brewer
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

9.  Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques.

Authors:  Shaoping Xu; Ali H Chamseddine; Samuel Carrell; Francis J Miller
Journal:  Redox Biol       Date:  2014-04-15       Impact factor: 11.799

10.  Roles of the kinase TAK1 in CD40-mediated effects on vascular oxidative stress and neointima formation after vascular injury.

Authors:  Zifang Song; Xiaolei Zhu; Rong Jin; Cuiping Wang; Jinchuan Yan; Qichang Zheng; Anil Nanda; D Neil Granger; Guohong Li
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

View more
  30 in total

Review 1.  Inflammation as a mediator of arterial ageing.

Authors:  Daniel W Trott; Paul J Fadel
Journal:  Exp Physiol       Date:  2019-08-08       Impact factor: 2.969

2.  Effects of N-acetyl cysteine on mitochondrial ROS, mitochondrial dynamics, and inflammation on lipopolysaccharide-treated human apical papilla cells.

Authors:  Nutcha Jariyamana; Patchanee Chuveera; Anat Dewi; Warat Leelapornpisid; Jitjiroj Ittichaicharoen; Siriporn Chattipakorn; Tanida Srisuwan
Journal:  Clin Oral Investig       Date:  2021-01-06       Impact factor: 3.573

Review 3.  Redox Control of Vascular Function.

Authors:  Joseph C Galley; Adam C Straub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-12       Impact factor: 8.311

4.  Renal NOXA1/NOX1 Signaling Regulates Epithelial Sodium Channel and Sodium Retention in Angiotensin II-induced Hypertension.

Authors:  Aleksandr E Vendrov; Mark D Stevenson; Andrey Lozhkin; Takayuki Hayami; Nathan A Holland; Xi Yang; Nicholas Moss; Hua Pan; Samuel A Wickline; James D Stockand; Marschall S Runge; Nageswara R Madamanchi; William J Arendshorst
Journal:  Antioxid Redox Signal       Date:  2022-03       Impact factor: 8.401

Review 5.  Proinflammatory Arterial Stiffness Syndrome: A Signature of Large Arterial Aging.

Authors:  Mingyi Wang; Robert E Monticone; Kimberly R McGraw
Journal:  J Vasc Res       Date:  2018-08-02       Impact factor: 1.934

Review 6.  Mechanism of Gene-Environment Interactions Driving Glial Activation in Parkinson's Diseases.

Authors:  Souvarish Sarkar
Journal:  Curr Environ Health Rep       Date:  2021-05-27

7.  NADPH Oxidase 4 Regulates Inflammation in Ischemic Heart Failure: Role of Soluble Epoxide Hydrolase.

Authors:  Mark D Stevenson; Chandrika Canugovi; Aleksandr E Vendrov; Takayuki Hayami; Dawn E Bowles; Karl-Heinz Krause; Nageswara R Madamanchi; Marschall S Runge
Journal:  Antioxid Redox Signal       Date:  2018-12-28       Impact factor: 8.401

Review 8.  Redox regulation of the actin cytoskeleton and its role in the vascular system.

Authors:  Qian Xu; Lauren P Huff; Masakazu Fujii; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2017-03-08       Impact factor: 7.376

9.  Hepatic transcriptional profile reveals the role of diet and genetic backgrounds on metabolic traits in female progenitor strains of the Collaborative Cross.

Authors:  Myungsuk Kim; M Nazmul Huda; Annalouise O'Connor; Jody Albright; Blythe Durbin-Johnson; Brian J Bennett
Journal:  Physiol Genomics       Date:  2021-04-05       Impact factor: 3.107

10.  Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma.

Authors:  Daniel A Rauch; John C Harding; Lee Ratner; Samuel A Wickline; Hua Pan
Journal:  Nanomaterials (Basel)       Date:  2021-06-16       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.